Korea's Golden Brain Care raises seed round for AI speech therapy
What's the deal? Golden Brain CareDealroom has a profile for this one. Try Dealroom →, a Busan-based startup building an AI-powered speech-rehabilitation platform, has raised an undisclosed seed round from accelerator series venturesDealroom has a profile for this one. Try Dealroom →, announced in September. Founded in 2026, it develops Brain Friends, a platform for patients with communication difficulties caused by stroke, brain injury, dementia, and other neurological conditions.
What's the endgame? Brain Friends links language assessment, tailored rehabilitation training, performance-data analysis, and caregiver reports into one flow. The platform analyses voice, facial movement, and response data with AI, and uses on-device processing to minimise external transfer of sensitive audio and video.
Why now? South Korea has more than one million cerebrovascular-disease patients, many with communication disorders such as aphasia. Assessments and training have largely been recorded on paper, making it hard to build structured data or manage repeat exercises outside the clinic.
What's the plan? The company will first test commercial viability through public-service vouchers and institutional SaaS subscriptions, then expand into regulated digital-therapeutic territory. It has been selected for clinical-data and testing-lab programmes, including at Konyang University Hospital, offering an early validation path.
Founder and chief executive officer Lee Hyun-song is a certified first-grade speech-language pathologist. "Losing speech is more than a difficulty in communication; it deeply affects daily life and relationships," he said, adding the funding would raise the product's clinical evidence base.
Series ventures co-chief executives Kwak Sung-wook and Park Jun-sang said Golden Brain Care "is turning the actual speech-rehabilitation process into a product" on the back of its founder's field expertise, and called its staged expansion strategy "realistic."
The signal: The round lands amid broader Korean investment in AI-enabled rehabilitation, though recent deals have gone to adjacent fields such as musculoskeletal care and wearable neurorehabilitation rather than direct speech-therapy rivals. The round's significance stays modest until the company shows sustained adoption and evidence of better rehabilitation outcomes.
Read more: wowtale.net
Image credit: USDAgov
